Guided Therapeutics, Inc.
GTHP · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $19,605 | $19,710 | $6,829 | $8,601 |
| - Cash | $87 | $185 | $115 | $388 |
| + Debt | $2,368 | $2,264 | $2,011 | $2,159 |
| Enterprise Value | $21,886 | $21,789 | $8,725 | $10,372 |
| Revenue | $0 | $117 | $0 | $1 |
| % Growth | -100% | – | -100% | – |
| Gross Profit | $35 | $79 | -$25 | -$2 |
| % Margin | – | 67.5% | – | -200% |
| EBITDA | -$586 | -$627 | -$255 | -$494 |
| % Margin | – | -535.9% | – | -49,400% |
| Net Income | -$785 | -$811 | -$427 | -$652 |
| % Margin | – | -693.2% | – | -65,200% |
| EPS Diluted | -0.01 | -0.011 | -0.007 | -0.012 |
| % Growth | 8.3% | -60.3% | 44.7% | – |
| Operating Cash Flow | -$277 | -$169 | -$331 | -$332 |
| Capital Expenditures | -$2 | $0 | $0 | $0 |
| Free Cash Flow | -$279 | -$169 | -$331 | -$332 |